2009 Is Repeat DEXA Testing Necessary During Treatment With a Bisphosphonate Medscape

Description: Osteoporotic fractures are associated with high rates of morbidity and mortality. Medical therapy is available that can improve bone mineral density (BMD) and reduce the risk for fracture. The issue of whether to monitor the treatment of osteoporosis with dual-energy x-ray absorptiometry (DEXA) testing, however, is controversial. The current study, which is large and has a long follow-up period, finds that repeat DEXA testing during the first 3 years of treatment with a bisphosphonate is not beneficial.
Best Evidence Review: Is Repeat DEXA Testing Necessary During Treatment With a Bisphosphonate? Charles P. Vega, MD. Review of Bell KJ, Hayen A, Macaskill P, et al. Value of routine monitoring of bone mineral density after starting bisphosphonate treatment: secondary analysis of trial data. BMJ. 2009;338:b2266.